Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Becton Dickinson and Company (BDX) stocks in Canada

Learn how to easily invest in Becton Dickinson and Company stocks.

Becton Dickinson and Company is a medical instruments & supplies business based in the US. Becton Dickinson and Company stocks (BDX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $253.82 – an increase of 1.09% over the previous week. Becton Dickinson and Company employs 75,000 staff and has a trailing 12-month revenue of around $19.9 billion.

How to buy stocks in Becton Dickinson and Company

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Becton Dickinson and Company stock price (NYSE:BDX)

Use our graph to track the performance of BDX stocks over time.

Becton Dickinson and Company shares at a glance

Information last updated 2022-05-16.
Latest market close$251.14
52-week range$227.80 - $277.29
50-day moving average $258.80
200-day moving average $249.52
Wall St. target price$284.25
PE ratio 43.1469
Dividend yield $3.36 (1.4%)
Earnings per share (TTM) $5.76

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Becton Dickinson and Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Becton Dickinson and Company price performance over time

Historical closes compared with the close of $251.14 from 2022-05-19

1 week (2022-05-13) 1.09%
1 month (2022-04-20) -6.17%
3 months (2022-02-17) N/A
6 months (2021-11-18) 0.71%
1 year (2021-05-21) 2.72%
2 years (2020-05-20) 3.35%
3 years (2019-05-20) 9.50%
5 years (2017-05-19) 36.39%

Is Becton Dickinson and Company under- or over-valued?

Valuing Becton Dickinson and Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Becton Dickinson and Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Becton Dickinson and Company's P/E ratio

Becton Dickinson and Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Becton Dickinson and Company shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Becton Dickinson and Company's PEG ratio

Becton Dickinson and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1366. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Becton Dickinson and Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Becton Dickinson and Company's EBITDA

Becton Dickinson and Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.3 billion.

The EBITDA is a measure of a Becton Dickinson and Company's overall financial performance and is widely used to measure a its profitability.

Becton Dickinson and Company financials

Revenue TTM $19.9 billion
Operating margin TTM 15.01%
Gross profit TTM $9.6 billion
Return on assets TTM 3.46%
Return on equity TTM 7.23%
Profit margin 8.86%
Book value $84.83
Market capitalisation $70.8 billion

TTM: trailing 12 months

Becton Dickinson and Company's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Becton Dickinson and Company.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Becton Dickinson and Company's total ESG risk score

Total ESG risk: 33.76

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Becton Dickinson and Company's overall score of 33.76 (as at 01/01/2019) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Becton Dickinson and Company is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Becton Dickinson and Company's environmental score

Environmental score: 4.87/100

Becton Dickinson and Company's environmental score of 4.87 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Becton Dickinson and Company's social score

Social score: 20.06/100

Becton Dickinson and Company's social score of 20.06 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Becton Dickinson and Company's governance score

Governance score: 13.83/100

Becton Dickinson and Company's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Becton Dickinson and Company is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Becton Dickinson and Company's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Becton Dickinson and Company scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Becton Dickinson and Company hasn't always managed to keep its nose clean.

Becton Dickinson and Company share dividends

28%

Dividend payout ratio: 27.78% of net profits

Recently Becton Dickinson and Company has paid out, on average, around 27.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Becton Dickinson and Company shareholders could enjoy a 1.4% return on their shares, in the form of dividend payments. In Becton Dickinson and Company's case, that would currently equate to about $3.36 per share.

While Becton Dickinson and Company's payout ratio might seem fairly standard, it's worth remembering that Becton Dickinson and Company may be investing much of the rest of its net profits in future growth.

Becton Dickinson and Company's most recent dividend payout was on 30 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 8 June 2022 (the "ex-dividend date").

Have Becton Dickinson and Company's shares ever split?

Becton Dickinson and Company's shares were split on a 1025:1000 basis on 1 April 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1025 shares. This wouldn't directly have changed the overall worth of your Becton Dickinson and Company shares – just the quantity. However, indirectly, the new 2.4% lower share price could have impacted the market appetite for Becton Dickinson and Company shares which in turn could have impacted Becton Dickinson and Company's share price.

Becton Dickinson and Company share price volatility

Over the last 12 months, Becton Dickinson and Company's shares have ranged in value from as little as $227.7963 up to $277.29. A popular way to gauge a stock's volatility is its "beta".

BDX.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Becton Dickinson and Company's is 0.6525. This would suggest that Becton Dickinson and Company's shares are less volatile than average (for this exchange).

Becton Dickinson and Company overview

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site